(Z) -Orantinib
(Z) -Orantinib (SU6668) is a potent, orally bioavailable multi-kinase inhibitor targeting VEGFR2, PDGFRβ, and FGFR1. It demonstrates significant anti-angiogenic and anti-tumor activity in both cellular assays and in vivo models, making it a valuable research tool for studying tumor microenvironment and angiogenesis mechanisms.
Product Specifications
CAS Number
210644-62-5
Product Name Alternative
(Z) -SU6668, (Z) -SU-6668, (Z) -TSU68, (Z) -TSU-68, (Z) Orantinib, (Z) Orantinib, Orantinib
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.05% (May vary between batches)
Solubility
DMSO:40 mg/mL (128.89 mM)
Smiles
C (=C\1/C=2C (NC1=O) =CC=CC2) \C3=C (C) C (CCC (O) =O) =C (C) N3
Molecular Formula
C18H18N2O3
Molecular Weight
310.35
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
H00004625-Q01-25ug 25 µg
Recombinant Human MYH7 Protein - (Dry Ice)
Sign In for Pricing
View Details 
124446-AP 100 µL
CCL15 (C-C Motif Chemokine 15, Chemokine CC-2, HCC-2, Leukotactin-1, LKN-1, MIP-1 delta, Macrophage Inflammatory Protein 5, MIP-5, Mrp-2b, NCC-3, Small-inducible Cytokine A15, MIP5, NCC3, SCYA15) (AP) discontinued
Sign In for Pricing
View Details